The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
922889214 9228892 14 F 201303 20160706 20130412 20160714 EXP DE-TEVA-393012USA TEVA 67.00 YR M Y 81.00000 KG 20160714 MD DE DE

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
922889214 9228892 1 PS BENDAMUSTINE BENDAMUSTINE 1 Intravenous (not otherwise specified) U 22249 178.2 MG POWDER
922889214 9228892 2 SS BENDAMUSTINE BENDAMUSTINE 1 Intravenous (not otherwise specified) U 22249 183.6 MG POWDER
922889214 9228892 3 SS BENDAMUSTINE BENDAMUSTINE 1 Intravenous (not otherwise specified) U 22249 180 MG POWDER
922889214 9228892 4 SS BENDAMUSTINE BENDAMUSTINE 1 Intravenous (not otherwise specified) U 22249 178.2 MG SOLUTION FOR INJECTION
922889214 9228892 5 SS BENDAMUSTINE BENDAMUSTINE 1 Intravenous (not otherwise specified) U 22249 168.3 MG SOLUTION FOR INJECTION
922889214 9228892 6 SS Rituximab RITUXIMAB 1 Unknown U 0 765 MG
922889214 9228892 7 SS Rituximab RITUXIMAB 1 Unknown U 0 700 MG
922889214 9228892 8 SS Rituximab RITUXIMAB 1 Unknown U 0 671.25 MG
922889214 9228892 9 SS Rituximab RITUXIMAB 1 Unknown U 0 701.25 MG
922889214 9228892 10 SS Temsirolimus TEMSIROLIMUS 1 Unknown U 0 50 MG
922889214 9228892 11 SS Temsirolimus TEMSIROLIMUS 1 Unknown U 0 50 MG
922889214 9228892 12 SS Temsirolimus TEMSIROLIMUS 1 Unknown U 0 50 MG
922889214 9228892 13 SS Temsirolimus TEMSIROLIMUS 1 Unknown U 0 50 MG
922889214 9228892 14 C ALLOPURINOL. ALLOPURINOL 1 0
922889214 9228892 15 C MCP METOCLOPRAMIDE HYDROCHLORIDE 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
922889214 9228892 1 Non-Hodgkin's lymphoma
922889214 9228892 6 Non-Hodgkin's lymphoma
922889214 9228892 10 Non-Hodgkin's lymphoma

Outcome of event

Event ID CASEID OUTC COD
922889214 9228892 OT
922889214 9228892 HO
922889214 9228892 LT

Reactions reported

Event ID CASEID DRUG REC ACT PT
922889214 9228892 Asthenia
922889214 9228892 General physical health deterioration
922889214 9228892 Hypokalaemia
922889214 9228892 Neutropenia
922889214 9228892 Oesophageal carcinoma
922889214 9228892 Staphylococcal infection
922889214 9228892 Thrombocytopenia
922889214 9228892 Vomiting
922889214 9228892 Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
922889214 9228892 1 20130219 20130220 0
922889214 9228892 2 20130319 20130320 0
922889214 9228892 3 20130423 20130424 0
922889214 9228892 4 20130524 0
922889214 9228892 6 20130219 20130220 0
922889214 9228892 7 20130319 20130319 0
922889214 9228892 8 20130423 0
922889214 9228892 9 20130423 0
922889214 9228892 10 20130220 20130226 0
922889214 9228892 11 20130320 20130326 0
922889214 9228892 12 20130406 0
922889214 9228892 13 20130608 0